The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACHAOGEN INC | COM | 004449104 | 704 | 255,000 | SH | SOLE | 255,000 | 0 | 0 | ||
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 341 | 18,000 | SH | SOLE | 18,000 | 0 | 0 | ||
| ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 6,064 | 320,000 | SH | SOLE | 320,000 | 0 | 0 | ||
| ADAPTIMMUNE THERAPEUTICS PLC | SPONDS ADR | 00653A107 | 1,425 | 175,300 | SH | SOLE | 175,300 | 0 | 0 | ||
| AFFIMED N V | COM | N01045108 | 2,281 | 610,000 | SH | SOLE | 610,000 | 0 | 0 | ||
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 4,263 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
| AMAG PHARMACEUTICALS INC | COM | 00163U106 | 5,148 | 220,000 | SH | SOLE | 220,000 | 0 | 0 | ||
| AMARIN CORP PLC | COM | 023111206 | 2,693 | 1,760,000 | SH | SOLE | 1,760,000 | 0 | 0 | ||
| ARIAD PHARMACEUTICALS INC | COM | 04033A100 | 7,988 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
| AURIS MED HLDG AG | COM | H03579101 | 1,238 | 340,000 | SH | SOLE | 340,000 | 0 | 0 | ||
| AXOGEN INC | COM | 05463X106 | 11,363 | 2,120,000 | SH | SOLE | 2,120,000 | 0 | 0 | ||
| BIOLINERX LTD | SPONSORED ADR | 09071M106 | 255 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 3,971 | 220,000 | SH | SOLE | 220,000 | 0 | 0 | ||
| CARA THERAPEUTICS INC | COM | 140755109 | 5,318 | 855,000 | SH | SOLE | 855,000 | 0 | 0 | ||
| CHIASMA INC | COM | 16706W102 | 183 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
| CHIMERIX INC | COM | 16934W106 | 3,449 | 675,000 | SH | SOLE | 675,000 | 0 | 0 | ||
| CODEXIS INC | COM | 192005106 | 3,665 | 1,178,500 | SH | SOLE | 1,178,500 | 0 | 0 | ||
| CORIUM INTL INC | COM | 21887L107 | 1,390 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | ||
| CYNAPSUS THERAPEUTICS INC | COM PAR NO PAR | 23257Y859 | 1,440 | 121,000 | SH | SOLE | 121,000 | 0 | 0 | ||
| CYTRX CORP | COM PAR $.001 | 838828509 | 4,118 | 1,440,000 | SH | SOLE | 1,440,000 | 0 | 0 | ||
| DEPOMED INC | COM | 249908104 | 4,527 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
| EAGLE PHARMACEUTICALS INC | COM | 269796108 | 2,430 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
| EDGE THERAPEUTICS INC | COM | 279870109 | 1,693 | 185,000 | SH | SOLE | 185,000 | 0 | 0 | ||
| EVOKE PHARMA | COM | 30049G104 | 662 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
| FIBROGEN INC | COM | 31572Q808 | 6,919 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
| FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 3,847 | 590,000 | SH | SOLE | 590,000 | 0 | 0 | ||
| GERON CORP | COM | 374163103 | 3,869 | 1,325,000 | SH | SOLE | 1,325,000 | 0 | 0 | ||
| IMMUNOMEDICS INC | COM | 452907108 | 3,313 | 1,325,000 | SH | SOLE | 1,325,000 | 0 | 0 | ||
| IMPRIMIS PHARMACEUTICALS INC | COM NEW | 45323A201 | 4,963 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
| INOTEK PHARMACEUTICALS CORP | COM | 45780VAA0 | 4,773 | 645,000 | SH | SOLE | 645,000 | 0 | 0 | ||
| INTEC PHARMA LTD JERUSALEM | SHS | M53644106 | 2,629 | 638,000 | SH | SOLE | 638,000 | 0 | 0 | ||
| MEDGENICS INC | COM NEW | 58436Q203 | 6,854 | 1,557,700 | SH | SOLE | 1,557,700 | 0 | 0 | ||
| MEDIVATION INC | COM | 58501N101 | 667 | 14,500 | SH | SOLE | 14,500 | 0 | 0 | ||
| NABRIVA THERAPEUTICS AG | SPONSORED ADR | 62957M104 | 2,453 | 273,800 | SH | SOLE | 273,800 | 0 | 0 | ||
| NEKTAR THERAPEUTICS | COM | 640268108 | 688 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| NEURODERM LTD | ORD SHS | M74231107 | 544 | 38,500 | SH | SOLE | 38,500 | 0 | 0 | ||
| NIVALIS THERAPEUTICS INC | COM | 65481J109 | 417 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| OHR PHARMACEUTICAL INC | COM NEW | 67778H200 | 1,175 | 366,000 | SH | SOLE | 366,000 | 0 | 0 | ||
| OPHTHOTECH CORP | COM | 683745103 | 3,382 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
| PROTALIX BIOTHERAPEUTICS INC | COM | 74365AAB7 | 6,892 | 8,200,000 | SH | SOLE | 8,200,000 | 0 | 0 | ||
| PROTEON THERAPEUTICS INC | COM | 7437IL109 | 1,161 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| PROTHENA CORP PLC | SHS | G72800108 | 576 | 14,000 | SH | SOLE | 14,000 | 0 | 0 | ||
| RETROPHIN INC | COM | 761299106 | 2,049 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| SAGE THERAPEUTICS INC | COM | 78667J108 | 5,290 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | ||
| SUPERNUS PHARMACEUTICALS INC | COM | 868459108 | 1,906 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| TENAX THERAPEUTICS INC | COM | 88032L100 | 1,024 | 499,600 | SH | SOLE | 499,600 | 0 | 0 | ||
| TG THERAPEUTICS INC | COM | 88322Q108 | 3,536 | 415,000 | SH | SOLE | 415,000 | 0 | 0 | ||
| TRILLIUM THERAPEUTICS INC | COM NEW | 89620X506 | 1,804 | 195,000 | SH | SOLE | 195,000 | 0 | 0 | ||
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 6,964 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 2,796 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| XOMA CORP DEL | COM | 98419J107 | 1,044 | 1,350,000 | SH | SOLE | 1,350,000 | 0 | 0 | ||
| ZOGENIX INC | COM NEW | 98978L204 | 2,218 | 240,000 | SH | SOLE | 240,000 | 0 | 0 | ||